Small-molecule arginase inhibitors are currently described as promising therapeutic agents for the treatment of variety of diseases, including cancer. Arginase vaccination could induce Th1 inflammation at tumor sites where regulatory myeloid cells otherwise prevent lymphocyte infiltration. Creative Biolabs has extensive experience in the field of cancer vaccines and can provide arginase vaccine development for cancer therapy.